| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |